Arbyn, Marc
Rezhake, Remila
Yuill, Susan
Canfell, Karen
Article History
Received: 14 February 2020
Revised: 19 February 2020
Accepted: 26 February 2020
First Online: 3 April 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: K.C. is co-principal investigator of an unrelated investigator-initiated trial of cervical screening in Australia (Compass, ACTRN12613001207707 and NCT02328872), which is conducted and funded by the VCS Foundation (VCS), a government-funded health promotion charity. The VCS Foundation received equipment and a funding contribution from Roche Molecular Systems USA. However, neither K.C. nor her institution on her behalf (Cancer Council NSW) receives direct funding from industry for this trial or any other project. MA was supported by the European Society of Gynaecological Oncology; the Cancer Council of New South Wales, Sydney (Australia); the RISCC Network, funded by the Horizon 2020 programme, of DG Research and Innovation, European Commission and the High Authority for Health (Paris, France).
: ESGO, Cancer Council NSW (Australia) and European Commission, HAS (France).
Free to read: This content has been made available to all.